OakChart

Medtronic Plc

MDTHealthcare·Medical Devices·Ireland·Large·NYSE·Nov 11 • 3:59 PM ET

101.61+0.02 (0.02%)
2026-11-11 23:43 CET
Market cap
129,950.88 USD m
Revenue, TTM
37,541.00 USD m
Net income, TTM
5,230.00 USD m
Free cash flow, TTM
6,132.00 USD m
EPS diluted, TTM
4.06
P/E
25.02
Compare

Price

MDT against its 20, 50 and 200-day averages
2050200beatmissearnings
80.0090.00100.0052.8M105.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MDTclose 101.6120-day 97.7850-day 93.35200-day 88.25101.6152w high52w low

4.4% under the 52-week high of 106.33 on 26 Nov 2025. 52-week low 73.31 on 2 Jun 2026. Last 15 sessions, 14.1% high to low

Volume 0.27× normal · the line is the 50-bar volume average

Profile

MDT
52-week range, 86% of the way up
73.31106.33

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Galway, Ireland.

IndexS&P 500, RUI
Employees95000
IPONov 21, 1977
Beta0.56
ATR, 14d2.56
Rel volume0.27
Short float1.80%
Insider own0.09%
Inst own88.77%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap129.98B
Enterprise Value149.93B
Income5.23B
Sales37.54B
Book/sh39.24
Cash/sh6.89
Dividend Est.2.83 (2.78%)
Dividend TTM2.86 (2.81%)
Dividend Ex-DateSep 25, 2026
Dividend Gr. 3/5Y1.45% 4.13%
Payout76.20%
Employees95000
IPONov 21, 1977

Ratios

P/E25.02
Forward P/E15.89
PEG2.06
P/S3.46
P/B2.59
P/C14.74
P/FCF21.20
EV/EBITDA14.39
EV/Sales3.99
Quick Ratio1.54
Current Ratio2.07
Debt/Eq0.56
LT Debt/Eq0.51
Option/ShortYes / Yes

Earnings

EPS (ttm)4.06
EPS next Y6.40
EPS next Q1.33
EPS this Y8.09%
EPS next Y6.99%
EPS next 5Y7.72%
EPS past 3/5Y9.75% 6.95%
Sales past 3/5Y5.21% 3.84%
EPS Y/Y TTM12.28%
Sales Y/Y TTM9.77%
EPS Q/Q41.57%
Sales Q/Q13.73%
EarningsNov 24 BMO
EPS/Sales Surpr.4.44% 2.20%

Ownership

Insider Own0.09%
Insider Trans-5.67%
Inst Own88.77%
Inst Trans-0.06%
ROA5.68%
ROE10.66%
ROIC6.90%
Gross Margin60.56%
Oper. Margin19.93%
Profit Margin13.93%
SMA203.92%
SMA508.85%
SMA20015.14%
Trades-

Technical

Shs Outstand1.28B
Shs Float1.28B
Short Float1.80%
Short Ratio1.39
Short Interest22.95M
52W High106.33 -4.44%
52W Low73.31 38.60%
Volatility2.98% 2.46%
ATR (14)2.56
RSI (14)61.91
Beta0.56
Rel Volume0.27
Avg Volume16.52M
Volume4,389,045

Performance

Perf Week-3.19%
Perf Month9.25%
Perf Quarter12.18%
Perf Half Y33.33%
Perf YTD5.78%
Perf Year6.51%
Perf 3Y43.76%
Perf 5Y-15.03%
Perf 10Y23.81%
Recom1.84
Target Price104.27
Prev Close101.59
Price101.61
Change %0.02%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 07, 2026InitiatedBBarclaysEqual Weight$95-6.5%
Aug 27, 2026ReiteratedNNeedhamBuy$101 → $114+12.2%
Jul 28, 2026UpgradeUUBSNeutral → Buy$100-1.6%
Jun 04, 2026UpgradeBBTIG ResearchNeutral → Buy$90-11.4%
May 21, 2026ResumedGGoldmanNeutral$84-17.3%
Feb 13, 2026ResumedBBarclaysOverweight$116+14.2%
Feb 09, 2026UpgradeNNeedhamHold → Buy$121+19.1%
Feb 03, 2026ResumedCCitigroupBuy$117+15.1%
Jan 30, 2026ResumedWWells FargoOverweight$114+12.2%
Jan 06, 2026UpgradeWWilliam BlairMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
BSXBoston Scientific Corp65.41B
ABTAbbott Laboratories189.28B
SYKStryker Corp121.36B
EWEdwards Lifesciences Corp60.84B
DXCMDexcom Inc29.96B
ISRGIntuitive Surgical Inc155.83B
ZBHZimmer Biomet Holdings Inc20.34B
BDXBecton Dickinson & Co58.43B
BAXBaxter International Inc13.63B
TFXTeleflex Incorporated6.20B

Insider trading

latest 14 of 21
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Marinaro MichaelEVP, Pres MedSurg and AmericasOct 15 '26Sale96.0010,4201,000,320105,916Oct 16 06:02 PM
Martha GeoffreyChairman and CEOOct 15 '26Sale95.0050,0004,750,000277,866Oct 16 06:00 PM
Marinaro MichaelOfficerOct 15 '26Proposed Sale96.0010,4201,000,320Oct 15 05:00 PM
Martha GeoffreyOfficerOct 15 '26Proposed Sale95.0050,0004,750,000Oct 15 09:41 AM
KIIL HARRY SKIPEVP & President CardiovascularSep 16 '26Sale93.651,483138,88342,186Sep 17 04:17 PM
KIIL HARRY SKIPOfficerSep 16 '26Proposed Sale93.651,483138,889Sep 16 02:37 PM
Walter Matthew R.SVP, Chief HR OfficerJul 08 '26Sale83.153,102257,93135,694Jul 09 04:26 PM
Walter Matthew R.OfficerJul 08 '26Proposed Sale83.153,102257,931Jul 08 10:15 AM
KIIL HARRY SKIPEVP & President CardiovascularJun 08 '26Sale80.444,189336,96537,227Jun 09 04:16 PM
KIIL HARRY SKIPOfficerJun 08 '26Proposed Sale80.444,189336,965Jun 08 02:34 PM
Walter Matthew R.SVP, Chief HR OfficerMay 26 '26Option Exercise0.009,149041,529May 28 04:26 PM
Wall Brett A.EVP & Pres NeuroscienceMay 26 '26Option Exercise0.0026,907082,183May 28 04:26 PM
Martha GeoffreyChairman and CEOMay 26 '26Option Exercise0.0094,9630343,099May 28 04:25 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasMay 26 '26Option Exercise0.0018,994070,593May 28 04:25 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VIGVanguard Dividend Appreciation FTFAUM: 117.07B
CGDVCapital Group Dividend Value ETFAUM: 38.70B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B
VYMVanguard High Dividend Yield Indx ETFAUM: 83.15B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-24-1.334--9,48025
2026Q12026-09-011.4501.3881.1409,7569,54624
2025Q42026-06-031.5501.5400.9659,8079,62020
2025Q32026-02-171.3601.3370.8869,0178,91126
2025Q22025-11-181.3601.3141.0678,9618,86726
2025Q12025-08-191.2601.2290.8088,5788,37925
2024Q42025-05-211.6201.5810.8218,9278,81926
2024Q32025-02-181.3901.3601.0068,2928,32727
2024Q22024-11-191.2601.2500.9878,4038,27528
2024Q12024-08-201.2301.1990.8048,0047,89928
2023Q42024-05-231.4601.4510.4938,5898,45027
2023Q32024-02-201.3001.2620.9938,0897,95327
2023Q22023-11-211.2501.1820.6837,9847,92625
2023Q12023-08-221.2001.1100.5937,7027,56628
2022Q42023-05-251.5701.5540.8858,5448,25525
2022Q32023-02-211.3001.2700.9177,7277,53924

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY4.5904.9803.54528,91329,685
2020FY4.4404.3562.66330,11730,057
2021FY5.5505.6603.72931,68632,022
2022FY5.2905.2722.82031,22730,936
2023FY5.2005.1972.76432,36432,221
2024FY5.4905.4573.61433,53733,512
2025FY5.5305.5183.73036,36436,147
2026FY-5.977--39,048
2027FY-6.395--40,280
2028FY-6.912--42,100
2029FY-7.488--44,719
2030FY-8.090--45,993

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-10-2323019,4809,4239,538
2026Q2S2026-10-1623019,4809,4239,538
2026Q2S2026-10-1422019,4809,4239,538
2026Q2S2026-10-1322019,4809,4239,538
2026Q2S2026-10-1222019,4809,4239,538
2026Q2S2026-10-0922019,4809,4239,538
2026Q2S2026-10-0622019,4839,4449,538
2026Q2S2026-09-3022019,4839,4449,538
2026Q2S2026-09-2922019,4839,4449,538
2026Q2S2026-09-1422019,4829,4449,538
2026Q2S2026-09-0923019,4829,4449,538
2026Q2S2026-09-0223019,4819,4449,538
2026Q2S2026-09-0123019,4819,4189,546
2026Q2S2026-08-2423009,4889,3839,568

Estimate history

EPS, annual2.273.413.5452.6633.7292.822.7643.6143.7274.0619
Period201720182019202020212022202320242025TTM
EPS, quarterly0.8040.9871.0060.8210.8081.0670.8860.9651.144
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual29953305572891330117316863122732364335373636437541
Period201720182019202020212022202320242025TTM
Sales, quarterly791584038292892785788961901798079756
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual1354.2181340.6981341.0751345.4011330.7431330.8091311.3381281.9351280.1771280.047
Period201720182019202020212022202320242025MRQ
Shares, quarterly1282.4951282.5531283.2661281.9351281.8691281.9851283.3671280.1771280.047
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue37,541.0036,364.0033,537.0032,364.0031,227.0031,686.0030,117.0028,913.0030,557.00
Cost of Goods Sold Incl. D&A14,807.0014,446.0013,487.0012,911.0012,323.0011,762.0012,138.0011,025.0010,828.00
Gross Profit22,734.0021,918.0020,050.0019,453.0018,904.0019,924.0017,979.0017,888.0019,729.00
Selling, General and Administrative Excl. Other15,074.0014,642.0013,571.0013,357.0012,938.0012,780.0012,445.0012,272.0012,630.00
Research and Development2,918.002,873.002,732.002,735.002,696.002,645.002,493.002,331.002,330.00
Other Operating Expense179.00208.00286.00364.00455.00956.00155.00738.000.00
Operating Income7,481.007,068.006,193.005,732.005,511.006,188.005,379.004,878.007,099.00
Interest Expense724.00715.00729.00719.00583.00553.00617.00679.00987.00
Unusual Expense707.00930.00879.001,028.00729.00596.001,224.00835.00794.00
Net Income Before Taxes6,604.006,136.005,628.004,837.005,364.005,517.003,895.004,055.005,197.00
Income Taxes1,333.001,299.00936.001,133.001,580.00456.00265.00-751.00547.00
Consolidated Net Income5,270.004,837.004,692.003,704.003,784.005,062.003,630.004,806.004,650.00
Net Income From Continuing Operations5,232.004,801.004,662.003,676.003,758.005,040.003,606.004,789.004,631.00
Net Income5,230.004,801.004,662.003,676.003,758.005,039.003,606.004,789.004,631.00
EPS (Recurring)4.454.234.093.303.204.043.303.983.82
EPS (Basic, Before Extraordinaries)4.083.753.632.772.833.752.683.573.44
EPS (Diluted)4.063.733.612.762.823.732.663.543.41
EBITDA10,421.0010,026.009,054.008,379.008,208.008,895.008,081.007,541.009,758.00
Non-Operating Income (Expense)552.00713.001,043.00852.001,165.00479.00357.00691.00-121.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense409.75381.00358.00329.00295.00297.00285.00246.00236.00
Price To Earnings Ratio25.0125.0125.7629.0529.9328.7749.2027.5525.97
Price To Sales Ratio2.922.953.243.283.884.455.894.643.88
Gross Margin60.5660.2759.7860.1160.5462.8859.7061.8764.56
Operating Margin19.9319.4418.4717.7117.6519.5317.8616.8723.23
Net Margin13.9313.2013.9011.3612.0315.9011.9716.5615.16
Shares Outstanding1,280.051,280.181,281.931,311.341,330.811,330.741,345.401,341.071,340.70
Market Capitalization129,950.88129,950.88108,708.09106,544.28121,001.70140,003.11176,489.32130,840.80119,067.35

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue9,756.009,807.009,017.008,961.008,578.008,927.008,292.008,403.00
Cost of Goods Sold Incl. D&A3,824.003,815.003,624.003,544.003,463.003,706.003,208.003,369.00
Gross Profit5,932.005,992.005,393.005,417.005,115.005,221.005,084.005,034.00
Selling, General and Administrative Excl. Other3,959.003,727.003,672.003,716.003,527.003,384.003,392.003,448.00
Research and Development771.00671.00722.00754.00726.00684.00675.00697.00
Other Operating Expense0.00208.000.00-29.0071.00337.00-31.008.00
Operating Income1,973.002,057.001,721.001,730.001,517.001,500.001,723.001,578.00
Interest Expense186.00176.00181.00181.00176.00174.00179.00209.00
Unusual Expense108.00278.00293.0028.00268.00608.00146.0018.00
Net Income Before Taxes1,769.001,834.001,404.001,597.001,302.001,261.001,540.001,559.00
Income Taxes289.00575.00254.00215.00255.00199.00237.00281.00
Consolidated Net Income1,479.001,259.001,150.001,382.001,047.001,062.001,303.001,278.00
Net Income From Continuing Operations1,470.001,243.001,144.001,375.001,040.001,057.001,294.001,269.00
Net Income1,470.001,243.001,143.001,374.001,040.001,057.001,294.001,270.00
EPS (Recurring)1.201.121.051.080.951.151.091.00
EPS (Basic, Before Extraordinaries)1.150.970.891.070.810.821.010.99
EPS (Diluted)1.140.960.891.070.810.821.010.99
EBITDA2,702.002,774.002,470.002,475.002,265.002,340.002,407.002,253.00
Non-Operating Income (Expense)89.00231.00156.0076.00229.00543.00140.00207.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense98.7581.0077.00153.0071.0073.0081.00134.00
Price To Earnings Ratio25.0122.6027.8125.0424.9525.7627.7230.03
Price To Sales Ratio2.922.953.673.473.503.233.493.53
Gross Margin60.8061.1059.8160.4559.6358.4961.3159.91
Operating Margin20.2220.9719.0919.3117.6816.8020.7818.78
Net Margin15.0712.6712.6815.3312.1211.8415.6115.11
Shares Outstanding1,280.051,280.181,283.371,281.981,281.871,281.931,283.271,282.55
Market Capitalization129,950.88103,956.57131,995.75116,339.98115,620.90108,708.09116,457.58114,462.23

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9,220.008,965.008,005.007,959.0010,573.0010,817.0010,948.009,848.0011,227.00
Short Term Receivables6,643.006,515.006,128.005,998.005,551.005,462.004,645.006,222.005,987.00
Inventories5,951.005,476.005,217.005,293.004,616.004,313.004,229.003,753.003,579.00
Other Current Assets2,973.002,858.002,585.002,425.002,318.001,956.002,209.002,144.002,187.00
Total Current Assets24,787.0023,814.0021,935.0021,675.0023,059.0022,548.0022,031.0021,967.0022,980.00
Net Property, Plant & Equipment8,614.007,937.007,143.006,610.006,267.006,219.005,755.004,675.004,604.00
Total Investments and Advances1,152.001,008.001,558.001,640.001,049.00709.00480.0044.0044.00
Long-Term Note Receivable-13.0058.00------
Intangible Assets52,733.0053,404.0054,211.0056,269.0056,097.0059,701.0058,904.0060,519.0061,266.00
Deferred Tax Assets3,943.004,040.003,657.003,477.003,403.003,169.002,832.001,519.001,465.00
Other Assets1,799.001,464.001,419.001,278.001,105.00737.00687.00970.001,034.00
Total Assets93,028.0091,680.0089,981.0090,948.0090,981.0093,083.0090,689.0089,694.0091,393.00
Short Term Debt Incl. Current Port. of LT Debt1,986.003,066.001,275.00200.003,909.00197.002,947.00838.002,058.00
Accounts Payable2,644.002,449.002,410.002,662.002,276.002,106.001,996.001,953.001,628.00
Income Tax Payable914.001,358.001,330.00840.00704.00435.00502.00567.00979.00
Other Current Liabilities6,114.006,006.005,774.005,349.005,505.005,771.004,921.005,114.005,419.00
Total Current Liabilities11,658.0012,879.0010,789.009,051.0012,394.008,509.0010,366.008,472.0010,084.00
Long Term Debt27,162.0026,560.0024,772.0025,213.0021,075.0027,207.0022,795.0024,486.0023,699.00
Provision for Risks Charges0.000.000.000.0084.00192.00168.00149.0065.00
Deferred Tax Liabilities362.00403.00515.00708.00884.001,028.001,174.001,278.001,423.00
Other Liabilities3,774.003,582.003,485.004,311.003,823.004,545.005,314.005,097.005,300.00
Total Liabilities42,956.0043,424.0039,561.0039,283.0038,260.0041,481.0039,817.0039,482.0040,571.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity49,463.0048,024.0050,214.0051,483.0052,551.0051,428.0050,737.0050,091.0050,720.00
Total Shareholders Equity49,463.0048,024.0050,214.0051,483.0052,551.0051,428.0050,737.0050,091.0050,720.00
Accumulated Minority Interest609.00232.00206.00182.00171.00174.00135.00121.00102.00
Total Equity50,072.0048,256.0050,420.0051,665.0052,722.0051,602.0050,872.0050,212.0050,822.00
Total Liabilities & Stockholders Equity93,028.0091,680.0089,981.0090,948.0090,982.0093,083.0090,689.0089,694.0091,393.00
Book Value Per Share38.6437.4638.2938.6939.4938.2337.8337.3637.45
Tangible Book Value Per Share-2.55-4.20-3.05-3.60-2.66-6.15-6.09-7.78-7.79
Full-Time Employees95,00095,00095,00095,00095,00090,00090,00090,00086,368
Price to Book Ratio2.592.202.102.352.673.422.582.382.14
Return on Assets5.205.134.064.135.483.925.315.113.25
Return on Equity9.859.497.237.229.697.069.509.196.15
Return on Invested Capital6.276.254.904.906.854.596.516.214.17
Quick Ratio1.621.421.551.811.492.141.722.151.92
Current Ratio2.131.852.032.391.862.652.132.592.28

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income5,269.004,837.004,691.003,705.003,784.005,062.003,630.004,806.004,650.00
Depreciation2,939.002,958.002,861.002,647.002,697.002,707.002,702.002,663.002,659.00
Other Funds (Non Cash)757.00907.00862.001,427.00751.001,070.001,031.001,019.001,082.00
Funds from Operations8,976.008,753.008,098.007,271.007,006.008,235.006,941.007,173.008,087.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-941.00-1,423.00-1,054.00-484.00-967.00-889.00-701.0061.00-1,080.00
Cash from Operating Activities8,035.007,330.007,044.006,787.006,039.007,346.006,240.007,234.007,007.00
Capital Expenditures-1,903.00-1,904.00-1,859.00-1,587.00-1,459.00-1,368.00-1,355.00-1,213.00-1,134.00
Net Assets From Acquisitions-1,568.00-406.00-98.00-211.00-1,867.00-91.00-994.00-488.00-1,827.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-511.00-620.00269.00-307.00-171.00-190.00-463.00-1,465.002,151.00
Purchase of Investments-8,815.00-8,725.00-8,226.00-7,748.00-7,514.00-9,882.00-11,808.00-11,039.00-2,532.00
Sale Or Maturity of Investments8,304.008,105.008,495.007,441.007,343.009,692.0011,345.009,574.004,683.00
Other Uses121.00-4.00-249.00-261.000.00-10.00-54.00-37.000.00
Other Sources26.000.000.000.004.000.000.000.0036.00
Cash from Investing Activities-3,834.00-2,934.00-1,937.00-2,366.00-3,493.00-1,659.00-2,866.00-3,203.00-774.00
Cash Dividends Paid-3,650.00-3,639.00-3,589.00-3,666.00-3,616.00-3,383.00-3,120.00-2,894.00-2,693.00
Change in Capital Stock-200.0019.00-2,727.00-1,854.00-337.00-2,115.00-178.00-664.00-1,885.00
Repurchase of Common Pref Stock-1,179.00-1,035.00-3,235.00-2,138.00-645.00-2,544.00-652.00-1,326.00-2,877.00
Sale of Common Pref Stock979.001,054.00508.00284.00308.00429.00474.00662.00992.00
Proceedsfrom Stock Options979.001,054.00508.00284.00308.00429.00474.00662.00992.00
Issuance or Reduction of Debt, Net151.00-1,174.002,139.001,073.00-598.00-1.00-570.00-559.00-867.00
Change in Long Term Debt-21.00-1,183.002,139.001,073.00-603.00-1.00-195.00-542.00-154.00
Issuance of Long Term Debt1,747.001,747.003,209.001,073.005,409.000.007,172.005,568.007,794.00
Reduction of Long Term Debt-1,768.00-2,930.00-1,070.000.00-6,012.00-1.00-7,367.00-6,110.00-7,948.00
Net Financing Active Other Cash Flow-14.0043.00-184.00-3.00-409.00163.00-268.00-81.0014.00
Other Financing Activities Uses0.000.00-184.00-3.00-409.000.00-268.00-81.000.00
Cash from Financing Activities-3,713.00-4,751.00-4,361.00-4,450.00-4,960.00-5,336.00-4,136.00-4,198.00-5,431.00
Exchange Rate Effect-70.0086.00188.00-230.00243.00-231.00215.00-86.00-78.00
Net Change in Cash418.00-269.00934.00-259.00-2,171.00120.00-547.00-253.00724.00
Free Cash Flow6,132.005,426.005,185.005,200.004,580.005,978.004,885.006,021.005,873.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow44.2160.0668.0269.15125.7454.35100.4342.9137.29
Deferred Taxes & Investment Tax Credit-51.00-316.00-508.00-226.00-604.00-422.00-1,315.00-304.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments8,819.009,220.008,383.008,327.008,121.008,965.00
Short Term Receivables6,357.006,643.006,359.006,389.006,263.006,515.00
Inventories6,215.005,951.006,309.006,156.005,886.005,476.00
Other Current Assets2,999.002,973.003,020.003,124.002,953.002,858.00
Total Current Assets24,390.0024,787.0024,071.0023,996.0023,223.0023,814.00
Net Property, Plant & Equipment7,473.008,614.007,179.007,164.007,006.007,937.00
Total Investments and Advances1,309.001,152.001,384.001,110.001,009.001,008.00
Intangible Assets53,425.0052,733.0052,227.0052,581.0053,230.0053,404.00
Deferred Tax Assets3,703.003,943.003,967.003,857.003,929.004,040.00
Other Assets3,006.001,799.002,657.002,581.002,525.001,464.00
Total Assets93,306.0093,028.0091,485.0091,346.0090,972.0091,680.00
Short Term Debt Incl. Current Port. of LT Debt2,536.001,986.00191.001,420.002,430.003,066.00
Accounts Payable2,695.002,644.002,569.002,581.002,555.002,449.00
Income Tax Payable1,056.00914.00650.00650.00933.001,358.00
Other Current Liabilities5,512.006,114.006,085.005,284.005,612.006,006.00
Total Current Liabilities11,799.0011,658.009,495.009,935.0011,530.0012,879.00
Long Term Debt25,617.0027,162.0027,880.0027,680.0026,179.0026,560.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities349.00362.00365.00386.00416.00403.00
Other Liabilities4,690.003,774.004,548.004,487.004,714.003,582.00
Total Liabilities42,455.0042,956.0042,288.0042,488.0042,839.0043,424.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity50,232.0049,463.0048,985.0048,652.0047,893.0048,024.00
Total Shareholders Equity50,232.0049,463.0048,985.0048,652.0047,893.0048,024.00
Accumulated Minority Interest618.00609.00211.00204.00240.00232.00
Total Equity50,850.0050,072.0049,196.0048,856.0048,133.0048,256.00
Total Liabilities & Stockholders Equity93,305.0093,028.0091,484.0091,344.0090,972.0091,680.00
Book Value Per Share39.2438.6438.1737.9537.3637.46
Tangible Book Value Per Share-2.49-2.55-2.53-3.06-4.16-4.20
Full-Time Employees-95,000---95,000
Price to Book Ratio2.592.122.712.432.412.20
Return on Assets5.685.205.095.265.165.13
Return on Equity10.669.859.389.819.729.49
Return on Invested Capital1.941.621.491.801.401.42
Quick Ratio1.541.621.871.801.501.42
Current Ratio2.072.132.542.422.011.85

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income1,479.001,259.001,150.001,381.001,047.001,061.00
Depreciation729.00716.00749.00745.00748.00840.00
Other Funds (Non Cash)123.00162.00244.00228.00273.00412.00
Funds from Operations2,458.002,129.002,042.002,347.002,235.002,078.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-665.00444.00702.00-1,422.00-1,147.00450.00
Cash from Operating Activities1,793.002,573.002,744.00925.001,088.002,528.00
Capital Expenditures-503.00-488.00-444.00-468.00-504.00-459.00
Net Assets From Acquisitions-1,162.00-406.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments19.00-30.00-347.00-153.00-90.00107.00
Purchase of Investments-2,190.00-2,153.00-2,371.00-2,101.00-2,100.00-2,133.00
Sale Or Maturity of Investments2,209.002,123.002,024.001,948.002,010.002,240.00
Other Uses0.006.00-10.00125.00-125.00-138.00
Other Sources26.000.00-14.0014.000.000.00
Cash from Investing Activities-1,619.00-917.00-816.00-482.00-719.00-490.00
Cash Dividends Paid-921.00-908.00-911.00-910.00-910.00-897.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-247.00200.0059.00-212.00-28.00-166.00
Repurchase of Common Pref Stock-267.00-435.00-105.00-372.00-123.00-274.00
Sale of Common Pref Stock20.00635.00164.00160.0095.00108.00
Proceedsfrom Stock Options20.00635.00164.00160.0095.00108.00
Issuance or Reduction of Debt, Net812.00-164.00-1,229.00732.00-513.000.00
Change in Long Term Debt0.000.000.00-21.00-1,162.00-1,070.00
Issuance of Long Term Debt0.000.000.001,747.000.000.00
Reduction of Long Term Debt0.000.000.00-1,768.00-1,162.00-1,070.00
Net Financing Active Other Cash Flow13.00-17.00-5.00-5.0070.00-280.00
Other Financing Activities Uses0.000.000.000.000.00-184.00
Cash from Financing Activities-343.00-888.00-2,087.00-395.00-1,381.00-1,343.00
Exchange Rate Effect-89.0034.0024.00-39.0067.00283.00
Net Change in Cash-258.00802.00-135.009.00-945.00978.00
Free Cash Flow1,290.002,085.002,300.00457.00584.002,069.00
Price to Free Cash Flow44.2160.0673.0075.7870.2867.90

Revenue breakdown

Ireland2024: 116.00M 2025: 143.00M
Other countries excluding United States and Ireland2024: 16.25B 2025: 18.12B
United States2024: 17.17B 2025: 18.10B
Cardiovascular2024: 12.48B 2025: 13.98B
Consolidation, Policy2024: -89.00M 2025: 39.00M
Diabetes Group2024: 2.76B 2025: 3.11B
Medical Surgical2024: 8.41B 2025: 8.82B
Neuroscience Group2024: 9.85B 2025: 10.29B
Other Operating Segment, Misc2024: 137.00M 2025: 135.00M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.80%23.0M1278.1M16.32M
2026-10-1510.88%139.0M1278.1M15.49M
2026-09-303.13%40.0M1278.1M8.78M
2026-09-151.35%17.2M1278.0M8.11M
2026-08-310.95%12.1M1278.0M8.71M
2026-08-141.12%14.4M1278.9M9.33M
2026-07-311.42%18.1M1278.8M9.90M
2026-07-151.49%19.0M1279.0M10.30M
2026-06-301.49%19.1M1278.8M10.21M
2026-06-151.44%18.4M1281.7M9.75M
2026-05-291.31%16.8M1282.6M9.15M
2026-05-151.14%14.6M1282.8M8.84M
2026-04-301.14%14.6M1282.8M8.76M
2026-04-151.20%15.5M1282.8M8.63M
2026-03-311.33%17.0M1280.6M8.52M
2026-03-131.30%16.6M1280.6M8.05M
2026-02-271.20%15.4M1280.6M7.49M
2026-02-131.35%17.3M1280.6M7.77M
2026-01-301.54%19.7M1280.8M7.24M
2026-01-151.31%16.8M1281.0M6.70M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call55.0044.7048.050.006.4740.000.000.998-0.0280.000
call60.0039.7043.050.005.7100.000.000.998-0.0280.000
call65.0034.7038.050.005.0030.000.000.988-0.1730.002
call70.0029.7033.050.004.3420.000.000.986-0.1690.003
call75.0024.7028.2526.713.7161.000.000.984-0.1640.003
call76.0023.7027.0525.733.5952.000.000.983-0.1630.003
call77.0022.7026.0524.753.4741.000.000.983-0.1620.003
call78.0021.7025.3523.653.3558.000.000.982-0.1600.003
call79.0020.7024.0521.723.2368.001.000.981-0.1590.003
call80.0019.7023.0520.703.1184.003.000.980-0.1580.003
call81.0018.6522.0519.773.0014.002.000.980-0.1560.004
call82.0017.7021.050.002.8850.000.000.979-0.1550.004
call83.0016.7020.050.002.7690.000.000.978-0.1530.004
call84.0015.7019.050.002.6540.000.000.977-0.1510.004
call85.0014.7518.000.002.5070.000.000.975-0.1490.004
call86.0013.7517.050.002.4240.000.000.974-0.1480.004
call87.0012.7516.052.872.3101.000.000.973-0.1460.005
call88.0011.7515.0513.362.19688.000.000.971-0.1430.005
call89.0010.7514.050.002.0820.000.000.969-0.1410.005
call90.0010.4513.059.601.96815.000.000.967-0.1390.005
call91.008.7512.0512.392.1527.000.000.965-0.1360.006
call92.008.4011.0510.231.7371560.000.958-0.1490.006
call93.006.7510.059.291.62129.000.000.945-0.1770.008
call94.007.059.107.901.52827.000.000.928-0.2090.010
call95.005.658.058.551.62735.000.000.898-0.2710.013
call96.004.557.056.501.26536.000.000.886-0.2600.014
call97.003.505.554.330.92353.001.000.880-0.2260.014
call98.002.575.103.701.03654.000.000.800-0.3480.020
call99.001.624.152.461.13026.007.000.724-0.4300.024
call1001.802.202.000.42254378.000.726-0.2580.024
call1010.691.891.030.5403465.000.567-0.4730.028
call1020.502.260.720.7162591.000.477-0.4890.029
call1030.040.860.250.49710393.000.352-0.3440.027
call1040.011.080.350.61898.000.000.321-0.4660.026
call1050.030.300.100.37715433.000.207-0.3080.021
call1060.001.230.050.45369.002.000.171-0.3040.018
call1070.002.150.250.52662.000.000.142-0.2930.016
call1080.000.280.290.59689.001.000.137-0.3300.016
call1090.002.130.000.6642.000.000.112-0.2970.014
call1100.000.010.010.4862914.000.015-0.0370.003
call1110.001.350.100.5142.000.000.015-0.0410.003
call1120.001.150.100.5592.000.000.008-0.0230.002
call1130.001.210.000.6040.000.000.007-0.0230.001
call1140.001.850.000.6480.000.000.007-0.0240.001
call1150.000.450.100.6902.000.000.006-0.0240.001
call1160.002.130.000.7340.000.000.006-0.0240.001
call1170.002.130.000.7760.000.000.006-0.0250.001
call1180.002.130.000.8170.000.000.005-0.0250.001
call1190.000.500.000.8560.000.000.005-0.0250.001
put55.000.002.130.003.0320.000.00-0.002-0.0290.000
put60.000.000.010.003.9480.000.00-0.031-0.4970.005
put65.000.002.130.002.9130.000.00-0.012-0.1740.002
put70.000.002.130.002.4800.000.00-0.014-0.1690.003
put75.000.002.130.252.0733.000.00-0.016-0.1630.003
put76.000.002.130.001.9940.000.00-0.017-0.1620.003
put77.000.002.130.001.9150.000.00-0.017-0.1610.003
put78.000.002.130.391.8387.000.00-0.018-0.1590.003
put79.000.002.130.051.7615.000.00-0.019-0.1580.003
put80.000.002.130.171.68511.000.00-0.019-0.1560.003
put81.000.002.130.371.6092.000.00-0.020-0.1550.004
put82.000.002.130.291.53410.000.00-0.021-0.1530.004
put83.000.002.130.221.46013.000.00-0.022-0.1520.004
put84.000.002.130.341.38632.000.00-0.023-0.1500.004
put85.000.001.550.111.31238.000.00-0.024-0.1480.004
put86.000.001.560.151.23915.000.00-0.026-0.1460.004
put87.000.001.350.401.1664.000.00-0.027-0.1440.005
put88.000.001.350.041.0941060.00-0.029-0.1410.005
put89.000.001.120.071.0224100.00-0.031-0.1390.005
put90.000.000.980.060.9501496.00-0.033-0.1360.005
put91.000.001.350.070.87851.000.00-0.035-0.1340.006
put92.000.001.350.600.80537.000.00-0.042-0.1460.006
put93.000.000.970.010.7333780.00-0.055-0.1750.008
put94.000.001.800.060.6613220.00-0.072-0.2060.010
put95.000.010.290.110.58897.008.00-0.090-0.2310.012
put96.000.000.300.040.5141782.00-0.113-0.2570.014
put97.000.030.090.090.43912315.00-0.120-0.2230.014
put98.000.020.180.160.43634.001.00-0.200-0.3450.020
put99.000.030.220.570.37259.001.00-0.252-0.3600.023
put1000.030.430.270.3701952.00-0.274-0.2550.024
put1010.101.620.550.67298.002.00-0.433-0.4700.028
put1020.491.691.040.52378.007.00-0.522-0.4850.029
put1031.002.053.000.4351258.00-0.648-0.3400.027
put1041.973.503.200.7291532.00-0.679-0.4620.026
put1052.234.604.370.88532.003.00-0.793-0.3040.021
put1064.055.605.350.99611.007.00-0.829-0.3000.018
put1074.006.603.851.1011.000.00-0.858-0.2890.016
put1085.758.300.001.4910.000.00-0.863-0.3250.016
put1096.759.300.001.5950.000.00-0.888-0.2920.014
put1107.7510.307.691.6954.000.00-0.972-0.0680.005
put1119.1011.259.571.7712.000.00-0.985-0.0360.003
put1129.7512.3010.491.8862.000.00-0.992-0.0180.002
put11310.7512.5510.811.6271.000.00-0.993-0.0190.001
put11412.0514.3011.732.0661.000.00-0.993-0.0190.001
put11512.7514.5513.481.7893.000.00-0.994-0.0190.001
put11613.9016.3014.402.2373.000.00-0.994-0.0190.001
put11714.9016.5515.401.9432.000.00-0.994-0.0190.001
put11815.9018.3016.412.4011.000.00-0.994-0.0200.001
put11916.7519.300.002.4800.000.00-0.995-0.0200.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-10-2111-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2026-10-21SEC
2026-10-2111-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2026-10-21SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-198-KCurrent report2026-10-15SEC
2026-10-16SCHEDULE 13G/ASEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-14SC TO-I/ASEC
2026-10-14425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-13SC TO-I/ASEC
2026-10-13425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-08425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-08SC TO-I/ASEC
2026-10-08425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-08425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-07425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-05425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-02425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-01425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-30425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-29425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-28425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-25425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10005.75M2
2026-0900138.88K1
2026-080000
2026-0700257.93K1
2026-0600336.97K1
2026-050000
2026-040000
2026-030000
2026-02005.13M1
2026-010000
2025-120000
2025-11003.06M1

Institutional holders

Manager% owned
BlackRock, Inc.8.91%
VANGUARD CAPITAL MANAGEMENT LLC6.55%
STATE STREET CORP4.95%
VANGUARD PORTFOLIO MANAGEMENT LLC2.66%
GEODE CAPITAL MANAGEMENT, LLC2.41%
JPMORGAN CHASE & CO2.17%
BANK OF AMERICA CORP /DE/1.67%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.55%
MORGAN STANLEY1.52%
DEUTSCHE BANK AG\1.41%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
VANGUARD 500 INDEX FUND2.60%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.30%
SPDR S&P 500 ETF TRUST1.22%
Bond Fund1.00%
VANGUARD VALUE INDEX FUND0.95%
State Street(R) Health Care Select Sector SPDR(R) ETF0.71%
First Eagle Global Fund0.71%
Income Fund of America0.58%

OakChart. MDT. Cached 15 minutes.